Palliative sedation can be used for refractory symptoms during end-of-life care. However, continuous palliative sedation (CPS) for existential distress remains controversial due to difficulty determining when this distress is refractory.
Objectives:
The aim was to determine the opinions and practices of Canadian palliative care physicians regarding CPS for existential distress.
Methods:
A survey focusing on experience and views regarding CPS for existential distress was sent to 322 members of the Canadian Society of Palliative Care Physicians.
Results:
Eighty-one surveys returned (accessible target, 314), resulting in a response rate of 26%. One third (31%) of the respondents reported providing CPS for existential distress. On a 5-point Likert-type scale, 40% of participants disagreed, while 43% agreed that CPS could be used for existential distress alone.
Conclusion:
Differing opinions exist regarding this complex and potentially controversial issue, necessitating the education of health-care professionals and increased awareness within the general public.
BushSHLeonardMMAgarM. End-of-life delirium: issues regarding recognition, optimal management, and the role of sedation in the dying phase. J Pain Symptom Manage. 2014;48(2):215–230. doi:10.1016/j.jpainsymman.2014.05.009.
2.
ChernyNIPortenoyRK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care. 1994;10(2):31–38.
3.
ChernyNI. Commentary: sedation in response to refractory existential distress: walking the fine line. J Pain Symptom Manage. 1998;16(6):404–406.
4.
National Ethics Committee, Veterans Health Administration. The ethics of palliative sedation as a therapy of last resort. Am J Hosp Palliat Care. 2007;23(6):483–491.
5.
Ten HaveHWelieJV. Palliative sedation versus euthanasia: an ethical assessment. J Pain Symptom Manage. 2014;47(1):123–136. doi:10.1016/j.jpainsymman.2013.03.008.
6.
SykesNThornsA. Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med. 2003;163(3):341–344.
7.
MaltoniMPittureriCScarpiE. Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol. 2009;20(7):1163–1169. doi:10.1093/annonc/mdp048.
8.
MaltoniMScarpiERosatiM. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol. 2012;30(12):1378–1383. Erratum in: J Clin Oncol. 2012;30(27):3429. doi:10.1200/JCO.2011.37.3795.
9.
ChernyNIRadbruchL; Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23(7):581–593. doi:10.1177/0269216309107024.
10.
KirkTWMahonMM; Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage. 2010;39(5):914–923. doi:10.1016/j.jpainsymman.2010.01.009.
11.
DeanMMCellariusVHenryBOneschukDLibrachSL; Canadian Society of Palliative Care Physicians Taskforce. Framework for continuous palliative sedation therapy in Canada. J Palliat Med. 2012;15(8):870–879. doi:10.1089/jpm.2011.0498.
12.
PutmanMSYoonJDRasinskiKACurlinFA. Intentional sedation to unconsciousness at the end of life: findings from a national physician survey. J Pain Symptom Manage. 2013;46(3):326–334. doi:10.1016/j.jpainsymman.2012.09.007.
AnquinetLRietjensJvan der HeideA. Physicians’ experiences and perspectives regarding the use of continuous sedation until death for cancer patients in the context of psychological and existential suffering at the end of life. Psychooncology. 2014;23(5):539–546. doi:10.1002/pon.3450.
15.
PapavasiliouESBrearleySGSeymourJEBrownJPayneSA; on behalf of EURO IMPACT. From sedation to continuous sedation until death: how has the conceptual basis of sedation in end-of-life care changed over time?. J Pain Symptom Manage. 2013;46(5):691–706. doi:10.1016/j.jpainsymman.2012.11.008.
16.
FainsingerRLDe MoissacDManciniIOneschukD. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care. 2000;16(2):5–10.
17.
de GraeffADeanM. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med. 2007;10(1):67–85.
18.
Schuman-OlivierZBrendelDHForsteinM. The use of palliative sedation for existential distress: a psychiatric perspective. Harvard Rev Psychiatry. 2008;16(6):339–351. doi:10.1080/10673220802576917.
19.
MoritaTTsunodaJInoueSChiharaS. Terminal sedation for existential distress. Am J Hosp Palliat Care. 2000;17(3):189–195.
20.
MoritaT. Palliative sedation to relieve psycho-existential suffering of terminally ill cancer patients. J Pain Symptom Manage. 2004;28(5):445–450.
21.
Van DeijckRHKrijnsenPJHasselaarJGVerhagenSCVissersKCKoopmansRT. The practice of continuous palliative sedation in elderly patients: a nationwide explorative study among Dutch nursing home physicians. J Am Geriatr Soc. 2010;58(9):1671–1678. doi:10.1111/j.1532-5415.2010.03014.x.
BraunTCHagenNAClarkT. Development of a clinical practice guideline for palliative sedation. J Palliat Med. 2003;6(3):345–350.
25.
ChaterSViolaRPatersonJJarvisV. Sedation for intractable distress in the dying—a survey of experts. Palliat Med. 1998;12(4):255–269.
26.
PapavasiliouEEPayneSBrearleyS; EUROIMPACT. Current debates on end-of-life sedation: an international expert elicitation study. Support Care Cancer. 2014;22(8):2141–2149. doi:10.1007/s00520-014-2200-9.
27.
van DeijckRHHasselaarJGKrijnsenPJ. The practice of continuous palliative sedation in long-term care for frail patients with existential suffering. J Palliat Care. 2015;31(3):141–149.
